Pillai, Radhakrishnan

Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials

Lebwohl, M. G., Papp, K. A., Marangell, L. B., Koo, J., Blauvelt, A., Gooderham, M., Wu, J. J., Rastogi, S., Harris, S., Pillai, R., et al. (2018) · Journal of the American Academy of Dermatology

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 179

Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug

Stein Gold, L., Baldwin, H., Kircik, L. H., Weiss, J. S., Pariser, D. M., Callender, V., Lain, E., Gold, M., Beer, K., Draelos, Z., et al. (2022) · American Journal of Clinical Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 51

Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups

Harper, J. C., Roberts, W. E., Zeichner, J. A., Guenin, E., Bhatt, V., & Pillai, R. (2020) · Journal of Dermatological Treatment

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 16